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Histologic analysis suggests that epidermal development
is complete in utero at µ34 wk gestational age. Infants
born more prematurely have elevated rates of both trans-
epidermal water loss and transcutaneous heat loss, and
have difficulty maintaining homeostasis. The under-
developed integument is also a portal of entry for infection
and the percutaneous uptake of toxins. Previous measure-
ments of transepidermal water loss have suggested that,
regardless of gestational age, competent barrier function
is attained within 2–4 wk postnatal age. In this study we
have utilized another noninvasive biophysical technique,
low frequency impedance spectroscopy, to complement
transepidermal water loss measurements. We present
The stratum corneum of a premature neonate is muchthinner than that of adults or full-term infants (Holbrook,1979, 1982; Evans and Rutter, 1986). Histologic assess-ment of abdominal skin samples from infants of differentgestational ages (24–40 wk) (Evans and Rutter, 1986)
indicated that, in utero, barrier development increased with gestational
age but that neither the stratum corneum nor the dermo–epidermal
undulations were visible until 34 wk gestational age, and that only
then was barrier maturation deemed to be complete. Thus, full-term
infants (40 wk gestational age) are born with a competent barrier,
comparable with that found in adults. In contrast, premature infants
of lower gestational age have a far less developed dermis/epidermis at
birth and consequently are ill-equipped to cope with ex utero conditions.
Barrier dysfunction is manifest by an inability to maintain homeostasis
owing to excessive fluid loss (resulting in dehydration and electrolyte
imbalance) and poor thermoregulation (Hammarlund and Sedin, 1979;
Rutter and Hull, 1979; Wilson and Maibach, 1980; Hammarlund et al,
1982; Harpin and Rutter, 1983). These infants are at further risk
because the poorly developed stratum corneum serves as a portal of
entry for infection (Leyden, 1982; Patrick, 1990; Askin, 1995), and
potential toxicity from topically applied substances (Nachman and
Esterley, 1971; Wester and Maibach, 1982).
In infants of less than 34 wk gestational age, but with a range of
postnatal ages, rapid epidermal cell differentiation occurs in the first
few weeks of life and, structurally, the skin of the most immature
infants resembles that of full-term infants by 2 wk of age (Evans and
Rutter, 1986). The stimulus for this burst of epidermal cell differenti-
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longitudinal data from infants ranging from 23 to 32 wk
gestational age. The results suggest that, for ultra-low
birth weight infants (23–25 wk gestational age), the
complete development of a fully functional stratum
corneum can require significantly longer than 4 wk. In
contrast, the data from the older infants suggest that a
postnatal existence period of 2–4 wk may not be necessary
to attain functional maturity, because infants born at 30
and 32 wk gestational age were found to have barrier
function comparable with that of adults. Key words:
impedance/neonatal development/stratum corneum/trans-
epidermal water loss. J Invest Dermatol 111:320–326, 1998
ation has been suggested to be the transition from a fluid (intrauterine)
to a terrestrial environment (Evans and Rutter, 1986).
A variety of techniques have been deployed to correlate skin barrier
maturation with gestational and postnatal age (Emery et al, 1991; Lynn
et al, 1993; Okah et al, 1995). Transepidermal water loss (TEWL)
has identified the significance of both gestational and postnatal age
(Hammarlund and Sedin, 1979; Rutter and Hull, 1979; Wilson and
Maibach, 1980; Hammarlund et al, 1982; Harpin and Rutter, 1983;
Sedin et al, 1985), the role of humidity (Hammarlund et al, 1977), and
the effects of therapeutic interventions on barrier integrity (e.g., the
effect of topical ointments or the removal of adhesives necessary to
secure temperature probes, intravenous lines, and monitor leads)
(Nopper et al, 1996; Lund et al, 1997). Histologic data and TEWL
measurements have been cited as evidence that 2–3 wk of postnatal
existence are sufficient to attain functional and structural integrity of
the stratum corneum regardless of gestational age (Harpin and Rutter,
1983; Evans and Rutter, 1986). None of these earlier studies, however,
had access to ultra-low birth weight infants, i.e., those of 23–25 wk
gestational age, because, until 10 y ago (and after most skin maturation
studies had been performed), nearly all infants younger than 26 wk
gestational age did not survive (Lane, 1987).
The majority of the literature presents ‘‘snapshots’’ of data from
different subjects at different gestational and postnatal ages and then
attempts to deduce by interpolation and extrapolation a model for
neonatal skin development. There is essentially no longitudinal data
with which to track the day-to-day changes in barrier function in a
specific infant as stratum corneum (and implicitly, epidermal) develop-
ment proceeds. We present detailed case histories documenting the
progressive evolution of barrier function. We have combined precise
TEWL data (Lund et al, 1997) with those from a second, noninvasive
and independent technique, namely impedance spectroscopy (IS) (Kalia
and Guy, 1995; Kalia et al, 1996a, b). The longitudinal results have
documented the maturation process in a cohort of low birth weight
infants, ranging from 23 to 32 wk gestational age.
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Table I. Infant characteristics, the period over which measurements were made, and the time of attainment of mature barrier
function
Infant Sex Weight Estimated Period of measurement Time of attainmemt of
(g) gestational age (wk) PNA (d) mature Z and TEWL values
F M 615 23 1–64 8–9 wk PNA
G F 580 24 7–57 7 wk PNA
E1 M 880 26 7–67 3–4 wk PNA
E2 F 700 26 7–64 4–5 wk PNA
J1 M 810 26 5/7 3–38 3–4 wk PNA
J2 M 820 26 5/7 3–38 3–4 wk PNA
J3 F 780 26 5/7 3–38 4–5 wk PNA
K F 995 28 1–25 3–4 wk PNA
C F 1200 30 5/7 5–11 From 1st day of measurement
H F 1650 32 1–9 From 1st day of measurement
MATERIALS AND METHODS
Electrodes The alternating current, required for the impedance measure-
ments, was applied using Tendertrace gel adhesive Ag/AgCl electrodes (NDM,
Dayton, OH). The area of the gel was 4 cm2, of which the electrode surface
occupied 0.79 cm2.
Experimental apparatus A Macintosh Quadra 800 (Apple, Cupertino, CA)
equipped with LabVIEW 3.0.1 (National Instruments, Austin, TX) was used
to control a signal generator (HP8116 A Pulse/Function Generator, Hewlett-
Packard, North Hollywood, CA). At an applied voltage of 1.0 V (peak-to-
peak), this produced a sinusoidal alternating current whose frequency was raised
from 1 Hz to 1 kHz incrementally with 10 frequency points sampled per
decade. The electrical circuit used for making the impedance measurements
included a 2 MΩ resistor in series with the skin. Thus, at the applied voltage
of 1.0 V (peak-to-peak), the sinusoidal current had an r.m.s. value of µ0.2 µA.
The potential difference across the skin was measured using a lock-in amplifier
(SR850 DSP, Stanford Research Instruments, Sunnyvale, CA). An isolation
transformer (Professional Design and Development Services, Berkeley, CA)
protected the human subject by ensuring complete isolation of the subject from
the mains power supply. TEWL measurements were made using a Servo Med
Evaporimeter EP1 (Servomed AB, Stockholm, Sweden) (Nilsson, 1977). All
data were analyzed using the Microsoft Excel (version 4.0 Copyright 1985–92)
software package.
Subjects Ten neonates admitted to the Intensive Care Nursery of Children’s
Hospital, Oakland, were enrolled in the study after informed parental consent
was obtained. All neonates appropriate for gestational age were eligible for the
study. Exclusion criteria included dermatologic disease or major congenital
anomalies. Gestational age was determined by maternal dates and corroborated
by physical examination of the infant. The research protocol was approved by
the Institutional Review Board of Children’s Hospital (Oakland, CA).
Experimental procedure The site of both TEWL and impedance measure-
ments was the subject’s calf (usually) or thigh. The leg was chosen because it
was easily accessible regardless of the infant’s position and of the manifold
therapeutic interventions occurring elsewhere on the body surface. (i) TEWL:
The sensing probe was held gently against the infant’s skin for a period of 90 s.
Data points were taken every 1.5 s and stored on an IBM compatible PC
equipped with an analog-digital conversion card (DT-2811, Data Translation,
Marlboro, MA) using custom software (Measurement Technologies, Cincinnati,
OH). A mean TEWL value was determined by averaging the data recorded
from t 5 30 to t 5 90 s. (ii) Impedance: After recording the TEWL
measurement, two gel-adhesive electrode pads were placed on the subject’s calf
(or thigh), µ2–3 mm apart (corresponding to a separation between the active
electrodes of 1.5 cm) and an impedance spectrum recorded. The measurement
required µ8 min.
RESULTS
Case 1: Infant F (see Table I) Figures 1(a) and (b) display,
respectively, the changes in TEWL and skin impedance as functions
of postnatal age (PNA, lower abscissa) and postconceptional age (PCA,
upper abscissa). Comparison of Figs 1(a) and (b) reveals clearly that
changes in low frequency impedance (1.6 Hz) are much more sensitive
to barrier maturation than the higher frequency parameter (note the
difference in the scales of the right ordinates in Fig 1a, b). Therefore,
although data were collected over a wide frequency range, only those
Figure 1. Infant F (estimated gestational age 23 wk). Development of
skin barrier function as assessed by increase of skin impedance (Z) and decrease
of transepidermal water loss (TEWL). Both (a) and (b) display the change in
TEWL (y-axis) and the change in Z (x-axis) at a specific frequency, either (a)
1.6 Hz or (b) 489 Hz, as functions of PNA (lower abscissa) and PCA (upper
abscissa). The solid arrow is a threshold impedance (Znorm) at 1.6 Hz for
competent barrier function. The shaded region indicates the range of basal
TEWL values (TEWLnorm) typically found in resting human subjects (5–10 per
gm2 per h). The impedance values are given per unit area (cm2) and correspond
to double the actual skin impedance value because the current path traverses
the stratum corneum twice.
at 1.6 Hz were used to compare TEWL and IS as probes of stratum
corneum maturation and barrier function.
Because of the need for ventilatory support and frequent therapeutic
interventions, Infant F was not placed in an incubator; rather, a radiant
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Figure 2. Correlation between skin impedance at 1.6 Hz and TEWL
for Infant G as a function of PNA and PCA.
warmer was used to maintain body heat. The baby was placed in a
‘‘humidified tent’’ to maintain elevated ambient humidity levels. The
first measurements were made at 15 h PNA. The skin impedance was
extremely low, µ0.5 kΩ, i.e., less than 1% of the value typical of a
mature barrier. Indeed, in adults, for example, such impedance values
are diagnostic of a completely deranged barrier with essentially complete
removal of the stratum corneum (Yamamoto and Yamamoto, 1976;
Kalia et al, 1996b). Visual observation revealed a very thin skin, with
the cutaneous vascular structure clearly visible. Barrier development in
this infant was very slow and it was evident, even at 5 wk PNA, that
this infant had not developed a useful cutaneous barrier. It was only
during the ninth week of measurement that the skin impedance climbed
above 250 kΩ and the TEWL decreased to 10 g per m2 per h.
Case 2: Infant G Infant G was enrolled in the study at 1 wk PNA
and the initial measurements (day 7) were made while the infant was
in an incubator at elevated humidity (µ80%) (Fig 2) (Hammarlund
et al, 1977; Harpin and Rutter, 1985). TEWL rose sharply once the
subject was removed from this environment, increasing from
15 to .30 g per m2 per h. Skin impedance was initially very low,
µ10 kΩ (7–11 d PNA). During the first week of measurement, the
infant’s back developed bright erythematous macular patches with
evidence of desquamation over approximately one-third of the affected
area and cultured positive for both Candida albicans and Coagulase
negative Staphylococcus, the latter also being found in the bloodstream.
There were no generalized or localized areas of papules or pustules.
Although the site of measurement was the calf, which was free from
skin lesions, it is conceivable that there may have been systemic effects
(Baley and Silverman, 1988; Faix et al, 1989; Rowen et al, 1995) that
influenced skin impedance and/or TEWL measurements. During the
seventh week of life, impedance rose steeply and reached the mature
value; TEWL decreased, approaching 10 g per m2 per h. Although
TEWL and low frequency impedance had changed rapidly during the
initial days of the study, both parameters then remained somewhat
invariant for several weeks before resolving quickly at the end of the
measurement period.
Case 3: Infants E1 and E2 Infants E1 and E2 were twins maintained
on ventilator support in an incubator for most of the study. The
increase in Infant E1’s skin impedance during the maturation process
is shown in Fig 3(a). The initial TEWL value was µ15 g per m2 per
h, which was artificially low due to the subject being maintained in
an environment of higher than ambient humidity. This ‘‘artifact’’ effect
was apparent when TEWL rose to µ25 g per m2 per h on the second
day of measurement (PNA 5 8 d) when the increased humidity had
been removed. The difference illustrates that elevated humidity can be
useful in reducing excessive fluid loss (Hammarlund et al, 1977; Harpin
and Rutter, 1985). Generally, TEWL followed a downward trend over
Figure 3. Correlation between skin impedance at 1.6 Hz and TEWL
for Infant E1 (a) and Infant E2 (b) as a function of PNA and PCA.
the measurement period and approached the upper limit (µ10 g per
m2 per h) of the adult/full-term infant range at µ3 wk PNA (although
day-to-day variations that resulted in higher TEWL were sometimes
observed). Skin impedance increased steadily from the first day of
measurement and attained values typical of adult skin at PNA 5 17–20 d.
In the case of the sibling, Infant E2, measurements were made on
the right calf and the left thigh (Fig 3b). Although the trends were
the same, skin impedance did not reach mature values until PNA µ 23–
25 d. Furthermore, TEWL values did not fall below µ10 g per m2
per h until PNA µ 30 d. Thus, there was an µ10 d differential in
barrier development of these twins. This may have been due to
inherent intersubject variability, E2 was considerably smaller than E1
(700 g, cf. 880 g at birth). There is not enough evidence, however,
to assume that intrauterine growth retardation was responsible for the
difference in development shown by twin E2, because it has been
found that the period of elevated TEWL is shorter in pre-term small-
for-gestational-age infants than in pre-term appropriate-for-gestational-
age infants (Hammarlund et al, 1983). Twin E2 also went through
major surgery, and was receiving parenteral nutrition, rather than
formula or breastmilk feedings. This may also have contributed to
delayed development of many organs, including the skin; however, a
drug treatment-related effect is also possible, although both twins were
given dexamethasone, indomethacin, and dopamine, Infant E2 received
dexamethasone for a much longer period (µ6 wk) than her sibling (4 d).
The measurements on the left thigh at PNA 5 47 d were particularly
interesting. By this stage of maturation, both TEWL and skin impedance
had attained reasonably stable values, µ10 g per m2 per h and ù200 kΩ,
respectively; however, the skin impedance at PNA 5 47 d was only
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µ20% of that on the previous day. TEWL was also elevated to µ15 g
per m2 per h. Investigation of the cause of the observation revealed
that the temperature of the incubator had increased to 36.6°C (cf.
30.5°C on the previous day) because the servo-controlled skin temper-
ature probe had become dislodged; this resulted in E2’s axillary
temperature climbing to 37.8°C. Therefore, the anomalously low
impedance and elevated TEWL were probably due to a temperature-
related perturbation of the barrier function.
Case 4: Infants J1, J2, and J3 These triplets were in incubators
throughout the study (Fig 4a–c). For measurements on days 4–7, the
humidity was elevated and this suppressed TEWL to ,20 g per m2
per h; however, when the humidity was removed, TEWL increased
to 20–30 g per m2 per h for Infants J1 and J3. There was a smaller
effect on TEWL in Infant J2 suggesting that this infant possessed more
efficient barrier function (note also that, during this period, Infant J2
also had higher impedance values than his siblings). All three infants
were almost 5 wk PNA before TEWL attained the ‘‘normal’’ range,
J1 and J3 again taking slightly longer than their sibling. Dexamethasone
was administered to each triplet, but with different dosage regimens.
Infant J1 received an initial dose of 0.05 mg every 12 h for 20 d,
which was then gradually tapered to 0.07 mg every 48 h over the next
3 wk. Infant J2 began at 0.07 mg every 12 h for 12 d, tapering to
0.04 mg per day over the subsequent 10 d. Infant J3 was started at
0.14 mg every 12 h for 10 d, gradually falling to 0.05 mg every 48 h
over the following 3 wk.
Case 5: Infant K Infant K was under a radiant warmer when initial
measurements were made within 24 h of birth. Skin impedance began
at µ10 kΩ but rose steadily during the first week, reaching 100 kΩ
by day 7 (Fig 5). At 17 d PNA, skin impedance began to increase
sharply and soon attained the ‘‘mature’’ level. TEWL, which was 37 g
per m2 per h on day 1, decreased in the first week to less than 15 g
per m2 per h, where it remained for the duration of the study.
Case 6: Infant C Infant C was on ventilator support in an incubator
throughout the study, during which time her TEWL was comparable
with the range of values (µ5–10 g per m2 per h) (Fig 6) found in
adults and in full-term infants. From the second day of study (PNA ù
6 d), impedance was also in the mature range (Fig 6). The results are
remarkable because the literature suggests that (i) the stratum corneum
does not develop before 34 wk gestational age and (ii) for more
premature infants, at least 2–3 wk postnatal existence is required for
development of a mature barrier (Hammarlund and Sedin, 1979; Rutter
and Hull, 1979; Harpin and Rutter, 1983; Evans and Rutter, 1986).
Case 7: Infant H This infant was maintained under a radiant warmer.
From the initial measurements, competent barrier function was apparent
(Fig 7). Skin impedance was always .200 kΩ except for 2 d when it
was no less than 90% of this value. TEWL was 5–10 g per m2 per h
for all but 1 d. Visually, the skin appeared fully mature. Infant H did
not receive any medication.
DISCUSSION
TEWL and impedance spectroscopy: noninvasive probes for
skin barrier maturation The stratum corneum has been likened to
a brick and mortar mosaic, comprising protein-filled keratinocytes
embedded in a multilamellar lipid matrix (Elias, 1991). The tortuosity
of the dominant intercellular transport route contributes to the efficient
barrier properties (Potts and Francoeur, 1990, 1991). Thus, structural
reorganization of the molecular architecture during maturation (perhaps
accompanied by compositional changes) would presumably cause a
concomitant increase in diffusion pathlength, thereby hindering ion
and water transport. These changes at the microstructural level, and
ensuing increased barrier efficiency, are manifest macroscopically in
the measured values of TEWL and impedance.
TEWL occurs because of the steep water concentration gradient
between the body’s interior and the external environments. The origin
of skin impedance is perhaps a little more difficult to understand.
During the impedance measurements, application of an alternating
electric field across the skin forces ions to move in the membrane.
Figure 4. Correlation between skin impedance at 1.6 Hz and TEWL
for Infant J1 (a), Infant J2 (b), and Infant J3 (c) as a function of PNA
and PCA.
The lipid-protein mosaic of the stratum corneum attenuates this
movement as a function of the dielectric properties of the different
domains within the membrane. The route of ion flow across the
stratum corneum depends upon the frequency of the applied potential
(Jack et al, 1975). At low frequencies, current flow is called ‘‘resistive’’
and is directly proportional to the applied potential. On the other
hand, at high frequencies the ‘‘capacitive’’ current increases as ions are
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Figure 5. Correlation between skin impedance at 1.6 Hz and TEWL
for Infant K as a function of PNA and PCA.
Figure 6. Correlation between skin impedance at 1.6 Hz and TEWL
for Infant C as a function of PNA and PCA.
now induced to flow by through-space polarization (Jack et al, 1975).
The results in Fig 1(a, b) for Infant F show that maturation has little
impact upon high frequency impedance, whereas changes in the low
frequency value are profound. The ‘‘capacitive’’ current flow is
determined by the frequency of the applied signal only (the rate of
change of the potential) and is insensitive to structural changes taking
place in the stratum corneum itself. By contrast, at low frequency, skin
impedance increases dramatically with barrier development. Ions in
the membrane are progressively more shielded from the applied electric
field as the stratum corneum becomes thicker and, concomitantly, the
diffusive pathlength becomes longer. The data presented here imply
that TEWL and low frequency impedance are correlated measures of
barrier function development despite the different mechanisms and
driving forces that underlie their origins. It is particularly interesting
to note how the inverse correlation between low frequency impedance
and TEWL progressively sharpens as barrier function develops (Fig 8).
At low gestational and postnatal ages, i.e., in the presence of an
immature barrier, TEWL is at its maximum (60–70 g per m2 per h)
and correlates with the lowest skin impedance. As the stratum corneum
develops and barrier function improves, the relationship between
TEWL and skin impedance becomes progressively more linear, mani-
festing a high degree of correlation (namely once TEWL falls below
20, the linear regression of 1/Z1.6Hz versus TEWL gives an r value of 0.8).
Chronology of barrier development The data from ultra-low
birth weight infants (F and G) suggest that the chronology of barrier
Figure 7. Correlation between skin impedance at 1.6 Hz and TEWL
for Infant H as a function of PNA and PCA.
Figure 8. Inverse correlation between impedance at 1.6 Hz and TEWL
as a function of PCA for infants born at less than 30 wk estimated
gestational age. Data from babies E1, E2, F, G, J1, J2, J3, and K.
development in this neonatal population should be revised (Figs 1, 2,
Table I). The infants did not display competent barrier function at 2–
4 wk PNA, as suggested by previous studies that considered older
subjects (Hammarlund et al, 1982; Evans and Rutter, 1986). Stratum
corneum development, as measured by TEWL and IS, did not appear
to be continuous. The first weeks of life were punctuated by quantal
bursts of improvement in barrier function, after which TEWL and
low frequency impedance remained relatively constant for periods of
up to several weeks (the day-to-day variation notwithstanding). For
both Infants F and G, however, there was significant maturation and
improvement of barrier function at 5–7 wk PNA.
The dependence of mean skin impedance and mean TEWL as a
function of PCA in those infants born at less than 30 wk estimated
gestational age (Fig 9) shows that acceleration in development of
barrier function occurred at 200–220 d PCA regardless of the relative
gestational and postnatal ages. This suggests that 30 wk PCA may
represent a key milestone in the development process (Figs 1–5);
however, it is unlikely that premature entry into a terrestrial environ-
ment fails to act as a stimulus for accelerated barrier development, and
it is a combination of gestational and postnatal age therefore that
determines the state and rate of development of barrier function;
Infants C and H (215 and 224 d estimated gestational age), for example,
possessed essentially competent barrier function throughout the
measurement period (Figs 6, 7). We again emphasize previous work,
including histologic analysis, which has suggested that epidermal
development does not reach fruition in utero until 34 wk gestational
age (Evans and Rutter, 1986). This raises the possibility that the
complete development of all dermal/epidermal structures may not be
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Figure 9. (a) Mean impedance (6SD) at 1.6 Hz and (b) mean TEWL
(6SD) as a function of PCA for infants born at less than 30 wk estimated
gestational age. Data from babies E1, E2, F, G, J1, J2, J3, and K.
necessary for competent barrier function, a suggestion consistent with
the observation that the stratum corneum is the principal permeability
barrier in mature skin. Therefore, ultrastructural investigations
addressing the issue of barrier competency should perhaps focus most
attention on the realization of normal stratum corneum architecture
alone as the key chronologic marker for the onset of mature barrier
function.
Thermoregulation (Infant E2) The very low skin impedance (and
increased TEWL) of Infant E2 on day 47 (Fig 3b) may have been
due to a transient perturbation of barrier function by the elevated
temperature. Differential scanning calorimetry and other biophysical
techniques have been used to examine the phase transition behavior
of stratum corneum (Potts, 1989). Several transitions have been
identified including one close to normal physiologic temperatures (Van
Duzee, 1975; Golden et al, 1986; Gay et al, 1994). It is also possible
that the reduced skin impedance was attributable to a rudimentary
sweating response. It has been found that, although babies born at less
than 36 wk gestational age do not exhibit sweating initially, they are
capable of doing so after a period of 2 wk postnatal existence (Harpin
and Rutter, 1982).
Effect of prenatal steroid administration on skin barrier develop-
ment (Infant C) Although prenatal administration of glucocorticoids
is used to promote fetal lung maturation (Liggins and Howie, 1972;
Avery, 1975), the effects (if any) of such treatment on neonatal skin
maturation are unknown; however, there is some evidence to support
the hypothesis that glucocorticoids may have such an effect (Ballard,
1986). In premature neonatal rats, maternal administration of beta-
methasone was found to accelerate maturation of the stratum corneum
lipid ultrastructure and increase total lipid content (Aszterbaum et al,
1993).
Effect of postnatal parenteral steroid administration on skin
barrier development Infants F and G both received dexamethasone
under a standard tapered dosing regimen (Avery et al, 1985) (Figs 1,
2). Barrier maturation appeared to improve rapidly after the administra-
tion of dexamethasone was terminated (at 5–6 wk). The twins, Infants
E1 and E2, differed considerably in the time taken to attain competent
barrier function. Significantly, Infant E2 received prolonged (µ5 wk)
postnatal parenteral steroid therapy, whereas her sibling was treated for
only 4 d from PNA 5 20 d. Similarly, of the triplets, Infant J3 was
given the highest initial dose and required the longest time to reach
the ‘‘mature’’ level of skin impedance. Premature infants receiving
pulsed dexamethasone treatment have shown growth retardation, and
skinfold thickness has been found to be reduced, during and after each
steroid pulse (Gilmour et al, 1995); however, following termination of
treatment, a period of ‘‘catch-up growth’’ ensued and at full-term
gestational age the infants had comparable body composition and size
to control groups (Gilmour et al, 1995).
In summary, it is clear that skin maturation in the premature neonate
is complex and that many different factors can have an impact on the
process. The number of subjects studied here is insufficient to resolve
the interplay, for example, between nutrition, medication, and the
influence of protective measures, such as humdification and warming.
More positively, the straightforward and noninvasive assessment of skin
barrier function described here affords the opportunity to examine the
feasibility of transdermal drug delivery and noninvasive monitoring
strategies in this highly vulnerable population (Evans and Rutter, 1989;
Barrett and Rutter, 1994) for whom conventional approaches are
either frequently difficult and/or hazardous.
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